PAVmed Inc.
PAVM· Nasdaq
Released Aug 14, 2020, after the close
10-Q filed Aug 14, 2020, 45 days after period end · 0001493152-20-015956
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Net Income | -$5.58M | -$3.59M | -$5.07M | -$989.71K |
| EPS Diluted | -$0.12 | -$0.13 | -$0.26 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PAVmed Inc. · CIK 1624326 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2020 · filed Aug 14, 2020 · 45 d after period end
6.0% from the close of Aug 14, 2020 to the close of Aug 19, 2020, the first after the release.